HK1244848A1 - 使用基因組特異性探針的循環腫瘤和腫瘤幹細胞檢測 - Google Patents

使用基因組特異性探針的循環腫瘤和腫瘤幹細胞檢測

Info

Publication number
HK1244848A1
HK1244848A1 HK18104134.9A HK18104134A HK1244848A1 HK 1244848 A1 HK1244848 A1 HK 1244848A1 HK 18104134 A HK18104134 A HK 18104134A HK 1244848 A1 HK1244848 A1 HK 1244848A1
Authority
HK
Hong Kong
Prior art keywords
tumor
stem cell
cell detection
specific probes
genomic specific
Prior art date
Application number
HK18104134.9A
Other languages
English (en)
Inventor
露絲．卡茨
Original Assignee
得克薩斯州大學系統董事會
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 得克薩斯州大學系統董事會 filed Critical 得克薩斯州大學系統董事會
Publication of HK1244848A1 publication Critical patent/HK1244848A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK18104134.9A 2014-12-10 2018-03-26 使用基因組特異性探針的循環腫瘤和腫瘤幹細胞檢測 HK1244848A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462090167P 2014-12-10 2014-12-10
PCT/US2015/065057 WO2016094698A1 (en) 2014-12-10 2015-12-10 Circulating tumor and tumor stem cell detection using genomic specific probes

Publications (1)

Publication Number Publication Date
HK1244848A1 true HK1244848A1 (zh) 2018-08-17

Family

ID=56108204

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18104134.9A HK1244848A1 (zh) 2014-12-10 2018-03-26 使用基因組特異性探針的循環腫瘤和腫瘤幹細胞檢測

Country Status (4)

Country Link
US (2) US20180127829A1 (zh)
CN (2) CN107208151A (zh)
HK (1) HK1244848A1 (zh)
WO (1) WO2016094698A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106970224B (zh) * 2017-03-16 2018-06-26 武汉康录生物技术股份有限公司 一种应用cd45免疫荧光联合cep探针鉴定循环肿瘤细胞的试剂盒及其应用
CA3063099A1 (en) 2017-06-21 2018-12-27 The Board Of Trustees Of The Leland Stanford Junior University Dosing parameters for cd47 targeting therapies to hematologic malignancies
WO2019083594A1 (en) * 2017-08-21 2019-05-02 The General Hospital Corporation COMPOSITIONS AND METHODS FOR CLASSIFYING TUMORS WITH INSTABILITY OF MICROSATELLITES
US20230220487A1 (en) * 2020-06-12 2023-07-13 Board Of Regents, The University Of Texas System Molecular markers and methods for sample analysis via mass spectrometry
US20230266325A1 (en) * 2020-06-30 2023-08-24 Lunglife Ai, Inc. Methods for detecting lung cancer
WO2023230531A1 (en) * 2022-05-24 2023-11-30 Lunglife Ai, Inc. Methods for detecting circulating genetically abnormal cells
CN115327114A (zh) * 2022-08-09 2022-11-11 江苏格诺生物科技有限公司 一种特异性小分子探针冻干技术

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8131053B2 (en) * 1999-01-25 2012-03-06 Amnis Corporation Detection of circulating tumor cells using imaging flow cytometry
US6797471B2 (en) * 2000-08-04 2004-09-28 Board Of Regents, The University Of Texas System Detection and diagnosis of smoking related cancers
US7736633B2 (en) * 2005-09-28 2010-06-15 E.I. Du Pont De Nemours And Company Method for enhancing effects of colorants and conditioners
US20070218480A1 (en) * 2006-01-25 2007-09-20 The Board Of Regents Of The University Of Texas System Detection and diagnosis of smoking related cancers
US8168383B2 (en) * 2006-04-14 2012-05-01 Cell Signaling Technology, Inc. Gene defects and mutant ALK kinase in human solid tumors
CN101587043B (zh) * 2008-05-20 2013-10-02 北京莱尔生物医药科技有限公司 从生物体液样本中富集与检测稀有细胞的整合方法
WO2010005991A2 (en) * 2008-07-07 2010-01-14 The Board Of Regents Of The University Of Texas System Circulating tumor and tumor stem cell detection using genomic specific probes
US20120129252A1 (en) * 2010-11-11 2012-05-24 Seubert Ronald C Method and system for cell filtration
US20120237931A1 (en) * 2011-03-14 2012-09-20 Katz Ruth L Identification and monitoring of circulating cancer stem cells
MX2014006884A (es) * 2011-12-09 2015-06-02 Gerd Marienfeld Aparato, sistema y metodo para identificar celulas tumorales circulantes.

Also Published As

Publication number Publication date
CN113528663A (zh) 2021-10-22
US20180127829A1 (en) 2018-05-10
WO2016094698A1 (en) 2016-06-16
US20210277481A1 (en) 2021-09-09
CN107208151A (zh) 2017-09-26

Similar Documents

Publication Publication Date Title
GB2552267B (en) Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
HK1244848A1 (zh) 使用基因組特異性探針的循環腫瘤和腫瘤幹細胞檢測
SG11201605906UA (en) Muscle-specific nucleic acid regulatory elements and methods and use thereof
SG11201606934SA (en) Improved reprogramming methods and cell culture platforms
HK1255101A1 (zh) 用於得到調節性t細胞的方法及其用途
SG11201607448PA (en) Determining cancer agressiveness, prognosis and responsiveness to treatment
GB2549635B (en) Data retention probes and related methods
GB2533284B (en) Performing object detection
PL3102704T3 (pl) Sondy oparte na oligonukleotydach i sposoby wykrywania drobnoustrojów
SG11201608934PA (en) Apparatuses and methods for performing multiple memory operations
GB201408516D0 (en) Neutron detection
LT3131577T (lt) Modifikuotos ląstelės-šeimininkės ir jų naudojimas
EP3107996A4 (en) Tscm cells and methods for use
GB201412043D0 (en) Cell positioning and analysis device
PL3132020T3 (pl) Naczynie do hodowli komórek i jego zastosowanie
HK1259296A1 (zh) 基因組規模的t細胞活性陣列及其使用方法
SG11201700274XA (en) Electrochemical detection of microorganisms
EP3100053A4 (en) Methods for the detection and quantification of circulating tumor cell mimics
IL251157B (en) Identification of disability with biological considerations
EP3350586C0 (en) METHOD FOR DETECTING CIRCULATING CELLS IN SURFACE BODY FLUIDS
EP3218482A4 (en) Hybridization probes and methods
SG11201610430QA (en) Growth-independent detection of cells
GB201405556D0 (en) Neutron detection
GB2539857B (en) Devices and methods for purification, detection and use of biological cells
GB201418980D0 (en) Cell assay kit and method